Immuron Ltd (IMRN)
2.64
-0.14
(-5.04%)
USD |
NASDAQ |
Mar 28, 15:15
Immuron EPS Diluted (TTM): -0.4481 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.4481 |
June 30, 2023 | -0.4397 |
December 31, 2022 | -0.3572 |
June 30, 2022 | -0.3615 |
December 31, 2021 | -0.5994 |
June 30, 2021 | -1.127 |
December 31, 2020 | -0.9602 |
Date | Value |
---|---|
June 30, 2020 | -0.4458 |
December 31, 2019 | -0.8114 |
June 30, 2019 | -0.9096 |
December 31, 2018 | -0.5863 |
June 30, 2018 | -0.7028 |
December 31, 2017 | -1.386 |
June 30, 2017 | -1.920 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-1.127
Minimum
Jun 2021
-0.3572
Maximum
Dec 2022
-0.646
Average
-0.5238
Median
EPS Diluted (TTM) Benchmarks
Mesoblast Ltd | 53.02 |
CERo Therapeutics Holdings Inc | -- |
Alterity Therapeutics Ltd | -0.7092 |
Kazia Therapeutics Ltd | -0.74 |
Immutep Ltd | -0.2247 |